Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.
Jérémy T CampilloCédric B ChesnaisSébastien D S PionJacques GardonJoseph KamgnoMichel BoussinesqPublished in: Parasites & vectors (2020)
To our knowledge, these results suggest for the first time in humans, that ivermectin has a partial prophylactic effect on O. volvulus. Three-monthly treatment seems more effective than annual treatment to prevent the appearance of nodules.
Keyphrases